特色

新闻 & 新闻 Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in bunionectomy, providing scientific consulting and conducting the study within our CRO and the ERG site network. Lotus applied our extensive expertise in the bunionectomy model and deployed our placebo response mitigation training program in order to minimize … 阅读更多

新闻 & 新闻 Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in total knee arthroplasty (TKA), providing scientific consulting and conducting the study within our CRO and the ERG site network. ERG-Lotus was able enroll this study far more rapidly than a typical TKA study, 在使用相对… 阅读更多

新闻 & 新闻 Lotus Clinical Research worked closely with Innocoll on this successful pivotal Phase 3 trial in abdominoplasty, providing scientific and regulatory consulting and conducting the study within our CRO and the ERG site network. Lotus pioneered the development of abdominoplasty as a postsurgical pain model beginning in 2010, 设计并执行了… 阅读更多

Lotus Clinical Research worked closely with Innocoll on the design of both new Phase 3 trials, and is currently conducting both studies within our CRO and site network: Innocoll Biotherapeutics plc Announces First Patients In Phase 3 Clinical Trials for Label Expansion of Xaracoll® (bupivacaine hydrochloride) Implant Results of implant’s safety, efficacy and pharmacokinetics for … 阅读更多

Lotus Clinical Research has worked with Concentric for several years and through multiple studies on their novel non-opioid analgesic vocacapsaicin. 最近, Lotus CRO has been instrumental in the study design, 协议编写与开发, 统计分析, management and oversight of Concentric’s total knee arthroplasty clinical trials at Lotus sites. Lotus also conducted Concentric’s earlier bunion … 阅读更多

Baudax Bio Non-Opioid Pain Drug Approval: In February, FDA granted approval to longtime Lotus client/ collaborator Baudax Bio’s non-opioid postsurgical pain therapy ANJESO. Lotus designed and performed both the Phase 2 and Phase 3 programs for this drug, with extensive scientific and operational input at every stage. The Baudax bunionectomy and abdominoplasty pivotal surgical studies … 阅读更多

2019年9月, 莲花收购HD Research, a network of specialty US analgesic research sites run by board certified anesthesiologists Harold Minkowitz, MD和David Leiman, MD. The core mission of our combined company is to standardize recruitment of chronic pain clinical trials using the same methodology Lotus used to standardize recruited models in acute … 阅读更多